Search results for “NK1 receptor antagonist” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 8,885 patents, we discovered top 468 key players by total patent application. F. Hoffmann-La Roche Ltd., Smithkline Beckman Corp, Merck Sharp & Dohme Corp. are dominant in this area. They take 14.15% of the total patent filing.
Switzerland
Patent: 523
Pennsylvania, United States
Patent: 386
New Jersey, United States
Patent: 348
Indiana, United States
Patent: 337
New Jersey, United States
Patent: 300
California, United States
Patent: 265
New Jersey, United States
Patent: 261
Basel-Stadt, Switzerland
Patent: 261
Hounslow, United Kingdom
Patent: 247
Antwerpen, Belgium
Patent: 234
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 47 patents, we discovered top 11 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, BenevolentAI Bio Ltd., SyntheX, Inc. are active in this area.
STARTUP
France
Patent: 29
United Kingdom
Patent: 3
STARTUP
California, United States
Patent: 3
STARTUP
Herefordshire, United Kingdom
Patent: 3
STARTUP
Guangdong Sheng, China
Patent: 2
STARTUP
California, United States
Patent: 2
STARTUP
North Carolina, United States
Patent: 1
STARTUP
Illinois, United States
Patent: 1
STARTUP
California, United States
Patent: 1
STARTUP
California, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 148 patents applied in the last 5 years. We discover 97 most active companies in this area. The fast-growing Tianjin Xiaoxin Pharmaceutical Technology Co., Ltd., Sandoz AG, Janssen Pharmaceutica NV take 8.78% of patent filing during this period.
Tianjin Shi, China
Patent: 5
Switzerland
Patent: 4
Antwerpen, Belgium
Patent: 4
Switzerland
Patent: 4
Aichi-ken, Japan
Patent: 4
United States
Patent: 3
Andhra Pradesh, India
Patent: 3
Tokyo-to, Japan
Patent: 3
Aichi-ken, Japan
Patent: 3
California, United States
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 148 patents in last 5 years, we discover 43 new entrants. Adeptio Pharmaceuticals Ltd., Nirsum Laboratories, Inc., Asahi Kasei Pharma Corp. are the most active new entrants in this area.
United Kingdom
Patent: 3
United States
Patent: 3
Tokyo-to, Japan
Patent: 3
Shanghai Shi, China
Patent: 3
United Kingdom
Patent: 3
Taiwan Province, China
Patent: 2
California, United States
Patent: 2
United States
Patent: 2
Anhui Sheng, China
Patent: 2
Yunnan Sheng, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 624 patents, we discovered top 103 universities and scientific research institutions by total patent application. Emory University, Yale University, The University of North Carolina at Chapel Hill are dominant in this area. They take 17.79% of the total patent filing.
Georgia, United States
Patent: 30
Connecticut, United States
Patent: 23
North Carolina, United States
Patent: 22
Fukuoka-ken, Japan
Patent: 19
Oregon, United States
Patent: 14
undefined undefined
Patent: 14
United States
Patent: 11
Jiangsu Sheng, China
Patent: 10
Illinois, United States
Patent: 9
New York, United States
Patent: 8
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: